Search results for "Skin Neoplasms"

showing 10 items of 282 documents

Photochemotherapy Alone or Combined with Interferon Alpha-2a in the Treatment of Cutaneous T-Cell Lymphoma

1990

Eighty-two patients with either mycosis fungoides (MF) or parapsoriasis en plaques were treated with psoralens ultraviolet A light (PUVA). Clinical and histologic parameters were followed for a period from 6 months to 10 years. Complete clinical clearing of lesions was observed in 51 patients (62%) and most of them were in limited-plaque MF group or parapsoriasis en plaque. The mean total dose of PUVA for complete clearing was less for early MF. Thirty-one patients (38%) relapsed and responded to additional PUVA. Patients in early stages of the disease remained clear for up to 68 months after the first course of PUVA. Post-treatment skin biopsies with early MF showed histologic clearing. A …

AdultMalemedicine.medical_specialtySkin NeoplasmsCombination therapyConstitutional symptomsDermatologyInterferon alpha-2BiochemistryMycosis FungoidesInterferonmedicineHumansSezary SyndromePUVA TherapyMolecular BiologyDepression (differential diagnoses)AgedNeoplasm StagingMycosis fungoidesParapsoriasisbusiness.industryCutaneous T-cell lymphomaInterferon-alphaCell BiologyMiddle Agedmedicine.diseaseCombined Modality TherapyDermatologyRecombinant ProteinsLymphoma T-Cell CutaneousDrug EvaluationFemalebusinessProgressive diseasemedicine.drugJournal of Investigative Dermatology
researchProduct

The Usefulness of Dermoscopy for the Recognition of Malignant Collision Tumors.

2021

<b><i>Background:</i></b> Preoperative diagnosis of malignant collision tumors (MCT) is extremely difficult. The value of dermoscopy to improve the correct detection of these tumors has not been previously studied. This study aims to evaluate the diagnostic accuracy of MCT with and without dermoscopy and to describe the dermoscopic features of a large series of MCT. <b><i>Methods:</i></b> Dermoscopic images of 161 MCT were evaluated. Clinical and dermoscopic images of histopathologically proven MCT intermingled with other tumors were randomly presented to clinicians with different levels of experience, blinded to the diagnosis and objective of…

AdultMalemedicine.medical_specialtySkin NeoplasmsKeratosisDiagnostic accuracyDermoscopyDermatologySensitivity and SpecificityDiagnosis DifferentialYoung AdultSquamous cell carcinomaMedicineNevusHumansCollision tumorBasal cellBasal cell carcinomaMedical diagnosisKeratosis SeborrheicMelanomaPhysical ExaminationAgedAged 80 and overNevus Pigmentedbusiness.industryMelanomaLarge seriesMiddle Agedmedicine.diseaseCarcinoma Basal CellBasal cell carcinomaFemaleCollision tumorsRadiologybusinessDermatology (Basel, Switzerland)
researchProduct

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

2015

The efficacy and safety of nab-paclitaxel versus dacarbazine in patients with metastatic melanoma was evaluated in a phase III randomized, controlled trial.Chemotherapy-naïve patients with stage IV melanoma received nab-paclitaxel 150 mg/m(2) on days 1, 8, and 15 every 4 weeks or dacarbazine 1000 mg/m(2) every 3 weeks. The primary end point was progression-free survival (PFS) by independent radiologic review; the secondary end point was overall survival (OS).A total of 529 patients were randomized to nab-paclitaxel (n = 264) or dacarbazine (n = 265). Baseline characteristics were well balanced. The majority of patients were men (66%), had an Eastern Cooperative Oncology Group status of 0 (7…

AdultMalemedicine.medical_specialtySkin NeoplasmsPaclitaxelDacarbazineGastroenterologyDisease-Free Survivallaw.inventionYoung AdultRandomized controlled triallawInternal medicineAlbuminsmedicineClinical endpointHumansProgression-free survivalAntineoplastic Agents AlkylatingMelanomaAgedAged 80 and overbusiness.industryMelanomaHazard ratioHematologyOriginal ArticlesMiddle Agedmedicine.diseaseChemotherapy regimenConfidence intervalSurgeryDacarbazineOncologyFemalebusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Occupational risk factors for mycosis fungoides: a European multicenter case-control study.

2004

Mycosis fungoides (MF) is a rare disease with an unknown etiology. Its distribution suggests that occupational exposures may play a role. In the present study, we searched for occupational factors associated with MF. A European multicenter case-control study on seven rare cancers, including MF, was conducted from 1995 to 1997. Patients between 35 and 69 years of age diagnosed with MF (n = 134) were identified and their diagnoses were checked by a reference pathologist who classified 83 cases as definitive, 35 cases as possible, and 16 cases as not histologically verified. Of the 118 histologically verified cases, 104 were interviewed, of which 76 were definitive cases. As controls, we selec…

AdultMalemedicine.medical_specialtySkin NeoplasmsPopulationMedizinOccupational medicineMycosis FungoidesRare DiseasesRisk FactorsInternal medicineEpidemiologymedicineHumansOccupationseducationAgededucation.field_of_studyMycosis fungoidesbusiness.industryPublic Health Environmental and Occupational HealthCase-control studyOdds ratioMiddle Agedmedicine.diseaseConfidence intervalSurgeryEuropeOccupational DiseasesLogistic ModelsCase-Control StudiesEtiologyFemalebusinessJournal of occupational and environmental medicine
researchProduct

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.

2021

Summary Background Before February, 2021, there was no standard treatment regimen for locally advanced basal cell carcinoma after first-line hedgehog inhibitor (HHI) therapy. Cemiplimab, a PD-1 antibody, is approved for treatment of advanced cutaneous squamous cell carcinoma and has shown clinical activity as monotherapy in first-line non-small-cell lung cancer. Here, we present the primary analysis data of cemiplimab in patients with locally advanced basal cell carcinoma after HHI therapy. Methods We did an open-label, multicentre, single-arm, phase 2 trial across 38 outpatient clinics, primarily at academic medical centres, in Canada, Europe, and the USA. Eligible patients (aged ≥18 years…

AdultMalemedicine.medical_specialtySkin NeoplasmsPyridinesProgrammed Cell Death 1 ReceptorVismodegibAntibodies Monoclonal Humanized030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaClinical endpointOutpatient clinicHumansBasal cell carcinomaAnilidesHedgehog ProteinsLung cancerImmune Checkpoint InhibitorsAgedbusiness.industryStandard treatmentMiddle Agedmedicine.diseaseRegimenOncologyCarcinoma Basal CellDrug Resistance Neoplasm030220 oncology & carcinogenesisFemaleNeoplasm Recurrence LocalSettore MED/35 - MALATTIE CUTANEE E VENEREEbusinessmedicine.drugThe Lancet. Oncology
researchProduct

Evaluation of the Upper Limb Lymphatic System: A Prospective Lymphoscintigraphic Study in Melanoma Patients and Healthy Controls

2016

Background Current research on the upper limb lymphatic system mainly studies breast cancer patients with unilateral lymphedema. Without preoperative lymphoscintigraphy, the contralateral limb is used as a control, assuming that it is functionally intact. Few lymphoscintigraphic studies investigate patients before any axillary surgery. The purpose of this study was to evaluate, through lymphoscintigraphy, the preoperative condition of the upper limb lymphatic system in melanoma patients and healthy controls. Methods Two groups were studied: the study group (16 patients with trunk/upper limb melanoma candidates for axillary sentinel lymph node biopsy) and the control group (10 healthy volunt…

AdultMalemedicine.medical_specialtySkin NeoplasmsSentinel lymph node030230 surgeryRisk AssessmentLymphatic SystemUpper Extremity03 medical and health sciencesPostoperative Complications0302 clinical medicineBreast cancerPreoperative CareHumansMedicineProspective StudiesLymphedemaSkin NeoplasmProspective cohort studyMelanomaAgedbusiness.industrySentinel Lymph Node BiopsyMiddle Agedmedicine.diseaseTrunkSurgeryAxillaProspective StudieLymphedemamedicine.anatomical_structureLymphatic systemCase-Control Studies030220 oncology & carcinogenesisAxillaUpper limbSurgeryFemaleRadiologyPostoperative ComplicationbusinessCase-Control StudieLymphoscintigraphyHuman
researchProduct

Presurgical Ultrasound-Guided Anchor-Wire Marking of Soft Tissue Metastases in Stage III Melanoma Patients

2001

Background. Due to increased sensitivity of diagnostic procedures, soft tissue metastases in melanoma patients are frequently detected very early. However, small sizes, deep location, or position close to vulnerable structures could render subsequent surgery quite difficult. Objective. To test the feasibility and effectiveness of presurgical ultrasound-guided anchor-wire marking of melanoma metastases. Methods. We selected melanoma patients with cytologically proven metastases in clinical stage III which were either unfavorably located or which have failed removal by previous surgery. Anchor-wire marking was performed ultrasound guided and free-hand style without the use of local anesthesia…

AdultMalemedicine.medical_specialtySkin NeoplasmsSoft Tissue NeoplasmsDermatologyPreoperative careMetastasisLesionPreoperative CareHumansMedicineLocal anesthesiaStage (cooking)MelanomaAgedUltrasonographybusiness.industryMelanomaSoft tissueGeneral MedicineMiddle Agedmedicine.diseaseUltrasound guidedSurgeryFeasibility StudiesFemaleSurgerymedicine.symptombusinessDermatologic Surgery
researchProduct

Operative management of epidural tumors of the spine

1994

Seventy-two patients with neoplastic involvement of the vertebral column were operated on between 1986 and 1991. In the course of 79 operations anterior decompression and stabilization alone were performed in 3 cases, while ventrodorsal spondylodesis was carried out in 10 individuals. The remainder of the patients underwent exclusively dorsal decompression and stabilization, mainly with the Cotrel-Dubousset instrumentation (CDI). No external spinal support was required following posterior fixation by CDI alone or in combination with ventral spondylodesis. Forty patients suffered from neurological deficits preoperatively, 20 of them being unable to walk, in most cases owing to severe vertebr…

AdultMalemedicine.medical_specialtySkin Neoplasmsgenetic structuresDecompressionEpidural TumorsPosterior fixationmedicineHumansOrthopedics and Sports MedicineAgedRetrospective StudiesFixation (histology)Aged 80 and overHistiocytoma Benign Fibrousbusiness.industryAnterior decompressionGeneral MedicineMiddle AgedSurgerymedicine.anatomical_structureAnesthesiaOrthopedic surgeryFemaleSurgeryEpidural NeoplasmsVertebral collapseMultiple MyelomabusinessVertebral columnArchives of Orthopaedic and Trauma Surgery
researchProduct

Characterizing psychosocial distress in melanoma patients using the expert rating instrument PO-Bado SF

2014

Background Although psychosocial distress has been evaluated well in cancer entities like breast or prostate cancer, its impact on melanoma patients still needs to be characterized. The objectives of this study were to (i) evaluate psychosocial distress in melanoma patients using an expert rating instrument [basic documentation for psycho-oncology short version (PO-Bado SF)]; (ii) determine associated demographic and clinical variables; and (iii) assess the acceptance of using PO-Bado SF as a routine procedure in a skin cancer unit. Methods A cross-sectional group of 696 melanoma patients was recruited. During the routine contact, doctors assessed the patients subjective distress using PO-B…

AdultMalemedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentDermatologyDiseaseProstate cancermedicineHumansMelanomaAgedAged 80 and overbusiness.industryCancerMiddle Agedmedicine.diseaseRadiation therapyDistressCross-Sectional StudiesInfectious DiseasesPhysical therapyAnxietyFemaleSkin cancermedicine.symptombusinessPsychosocialStress PsychologicalJournal of the European Academy of Dermatology and Venereology
researchProduct

Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy.

2019

Abstract Introduction Studies reporting incidences of non-melanoma skin cancer (NMSC) are heterogeneous, depend on the geographic area of the studied population and are often short-term. The aim of this study is to determine the incidence of NMSC in patients treated with oral PUVA therapy in the Mediterranean area. Material and methods A retrospective, observational study was carried out with a sample of 234 patients treated with systemic PUVA between 1982 and 1996, carrying out a historical follow-up until May 2017. The incidence density rate of CCNM (crude and adjusted) was calculated by direct standardisation. The incidence of CCNM was compared with that reported in the general populatio…

AdultMalemedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentPopulation03 medical and health sciences0302 clinical medicinemedicineCarcinomaHumansBasal cell carcinoma030212 general & internal medicineeducationPUVA Therapyeducation.field_of_studybusiness.industryIncidence (epidemiology)IncidenceAge FactorsMiddle Agedmedicine.diseaseDermatologyEpidermoid carcinomaCarcinoma Basal CellPUVA therapyCarcinoma Squamous CellObservational studyFemaleSkin cancerbusinessMedicina clinica
researchProduct